Tag
2 articles
The FDA has selected Dexcom as the first company to offer an unapproved device to Medicare patients under its new TEMPO pilot program, using enforcement discretion to accelerate access to digital health innovations.
The U.S. Department of Health and Human Services has launched an AI initiative to detect fraud and waste in federal health programs, shifting from a 'pay and chase' model to real-time screening.
